MarketPeel
Insider Trading Intelligence
Pricing
…
DS

Darren Snellgrove

HALO
SVP, CHIEF FINANCIAL OFFICER · HALOZYME THERAPEUTICS, INC. · CIK 0002137401
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jul 2026
HOLDINGS NOW
127,432
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Darren Snellgrove. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
HALO · 127,432 shares · as of Jul 1, 2026
031,85863,71695,574127,432SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
127,432——127,432Jul 1, 2026Jul 2, 2026 ↗View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
41,554——41,554Jul 1, 2026Jul 2, 2026 ↗View →
Other insiders · HALO
Loading peer insiders…
About this filer
CIK 0002137401
ROLE
SVP, Chief Financial Officer
PRIMARY
HALO
COMPANIES
1
ACTIVE SINCE
Jul 2026
MARKETPEEL · /INSIDER/0002137401DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback